The CFO's sale is routine and not materially concerning given its small size relative to market cap. Non-cash grants are standard compensation and should not be interpreted as trading signals. Monitor for additional selling or news ahead of next earnings.
Price Chart
Executive Summary
CRISPR Therapeutics CFO Prasad Raju sold $173,460 worth of shares in an open-market transaction, while both the CFO and Chief Medical Officer received non-cash equity awards totaling 140,748 shares. The only material transaction was the CFO's sale, which represents a small fraction of the company's $4.5B market cap.
Key Financial Metrics
Key Facts
- CFO Prasad Raju sold 3,708 shares for $173,460 in an open-market transaction on March 23, 2026.
- On March 20, 2026, CFO Raju received 65,999 shares and exercised 12,500 shares via derivatives, all non-cash events.
- Chief Medical Officer Naimish Patel received 68,499 shares in non-cash grants on March 20, 2026.
- Total open-market selling in the cluster: $173,460 (0.0038% of $4.5B market cap).
- No open-market purchases were made by insiders in this cluster.
Financial Impact
$173,460 in open-market sales by CFO, representing 0.0038% of market cap
Risk Factors
- CFO selling while holding newly granted shares could signal lack of conviction, though the amount is small.
- No insider buying to offset the sale, reducing potential bullish signal.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (7 trades, 7d window) | cluster-CRSP-1774388233457 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 5d ago | Insider Cluster | $50.50 | awaiting T+20 | — | $49.01 (+2.95%) |
Oct 19, 2026 7d ago | 8-K | $49.88 | awaiting T+20 | — | $49.01 (−1.74%) |
Oct 16, 2026 9d ago | Insider Cluster | $50.04 | awaiting T+20 | — | $49.01 (−2.06%) |
Oct 16, 2026 9d ago | Insider Cluster | $50.04 | awaiting T+20 | — | $49.01 (+2.06%) |
Oct 15, 2026 10d ago | Insider Cluster | $49.25 | awaiting T+20 | — | $49.01 (−0.49%) |
Oct 14, 2026 12d ago | 144 | $51.52 | awaiting T+20 | — | $49.01 (−4.87%) |
Oct 6, 2026 20d ago | 144 | $52.35 | awaiting T+20 | — | $49.01 (−6.38%) |
Sep 24, 2026 4w ago | Insider Cluster | $54.23 $49.39 | ▲ +8.92% | ▲ +7.45% | $49.01 (+9.63%) |
Aug 28, 2026 8w ago | Press Release | $57.72 $54.23 | ▼ −6.05% | ▼ −6.56% | $49.01 (−15.09%) |
Aug 3, 2026 12w ago | Press Release | $53.07 $56.82 | ▲ +7.07% | ▲ +8.30% | $49.01 (−7.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers